NIH Workshop on the Medical Utility of Marijuana
MAPS report(Turning Protests into Protocols: Dr. Harter´s Legacy) to NIDA’s Expert Panel on Medical Marijuana Research – submitted February 25, 1997 following the February 19-20, 1997 …
Cannabis
After Proposition 200 and 215
December 2, 1996 Senate Judiciary Committee Hearing on Medical Marijuana – A message to new visitors of the MAPS website. MAPS Policy in Response to Prop. 200 and Prop. 215
Families Who Value Psychedelics
In this section of the Rites of Passage project, families share their experiences creating their own contexts for psychedelics and marijuana. Just as each family is unique, each of the following accounts …
NIH Grant Application Process
NIH August 1996 Rejection and Critique of "Smoked Marijuana for HIV-Associated Anorexia and Wasting Protocol"
Water Pipe Study
Water Pipe Study by Dale H. Gieringer, Ph.D. (Summer 1996) Why Marijuana Harm Reduction? by Dale H. Gieringer, Ph.D. (Summer 1996)
FY 1996 Financial Report
This past fiscal year, which ran from June 1, 1995 to May 31, 1996, was MAPS' tenth and most successful ever in terms of both fund-raising and membership. I believe that at least part of this increasing …
Smoked Marijuana for HIV-Associated Anorexia and Wasting Protocol
Smoked Marijuana for HIV-Associated Anorexia and Wasting Protocol, (IND#43,542) submitted to the NIH May 1, 1996 by Dr. Donald Abrams.
A Dose/Response Human Pilot Study – Safety and Efficacy of MDMA in Modification of Physical Pain and Psychological Distress in End-Stage Cancer Patients
[This is not the current version of this protocol] Version 4.1 August 22, 1995 A DOSE/RESPONSE HUMAN PILOT STUDY – SAFETY AND EFFICACY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN MODIFICATION OF PHYSICAL …
FDA-Regulated Research and the Effort to Begin It
Dr. Donald Abrams’ FDA-approved research protocol, (IND#43,542) comparing the effectiveness of smoked marijuana and the oral THC capsule in promoting weight gain in patients suffering from the AIDS …
Medical Marijuana Clinical Plan
A comprehensive clinical plan developed by MAPS in consultation with the FDA for the investigation of marijuana’s medical use in the treatment of the HIV-related wasting syndrome. This Clinical Plan …
FY 1993 Financial Report
At the beginning of this fiscal year, MAPS had about 350 members and $897 in the bank. By the end of the fiscal year, MAPS' membership had doubled to 707 and its balance was $46,066 (consisting of …
FY 1992 Financial Report
You can read this report in its original form here. MAPS' total income in FY 91-92 was $28,859.55. The following categories had no expenditures this fiscal year. Public Relations/Ads, Salaries, Grants, …
